Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
14/08/202406:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ODPODP Corporation
14/08/202406:02PR Newswire (US)Garmin announces support of new Satellite SOS on Google Pixel smartphonesNYSE:GRMNGarmin Ltd
14/08/202406:02Business WireLes stars de la J-Pop animent le plus grand spectacle de mapping vidéo au monde sur le bâtiment du gouvernement métropolitain de Tokyo
14/08/202406:02PR Newswire (US)Sterlite Technologies Inc. to appeal verdict in South Carolina lawsuit; reinforces its commitment to the U.S. market
14/08/202406:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KPLTKatapult Holdings Inc
14/08/202406:01Alliance NewsAlliance NewsTOP NEWS: UK house price growth steadies while rent rises remain high
14/08/202406:01PR Newswire (Canada)/R E P E A T -- Media Advisory - CDPQ: FINANCIAL RESULTS AS AT JUNE 30, 2024/
14/08/202406:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:LPLLG Display Co Ltd
14/08/202406:00Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:RIOTRiot Platforms Inc
14/08/202406:00GlobeNewswire Inc.Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of ResearchNASDAQ:OMGAOmega Therapeutics Inc
14/08/202406:00GlobeNewswire Inc.Marex Group plc announces 2024 Interim ResultsNASDAQ:MRXMarex Group PLC
14/08/202406:00GlobeNewswire Inc.Creative Realities Reports Fiscal 2024 Second Quarter ResultsNASDAQ:CREXCreative Realities Inc
14/08/202406:00GlobeNewswire Inc.Cellebrite Appoints Tech Veteran Troy K. Richardson to Board of DirectorsNASDAQ:CLBTCellebrite Digital Intelligence Ltd
14/08/202406:00Business WireVolato Reports Second Quarter 2024 ResultsAMEX:SOARVolato Group Inc
14/08/202406:00GlobeNewswire Inc.Galera Announces Board Approval of Complete Liquidation and DissolutionNASDAQ:GRTXGalera Therapeutics Inc
14/08/202406:00Business WireSmith Douglas Homes Reports Second Quarter 2024 ResultsNYSE:SDHCSmith Douglas Homes Corp
14/08/202406:00Business WireBakkt Reports Second Quarter 2024 ResultsNYSE:BKKTBakkt Holdings Inc
14/08/202406:00Business WireViroCell Biologics Completes Oversubscribed Financing
14/08/202406:00GlobeNewswire Inc.Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business UpdatesNASDAQ:ACHLAchilles Therapeutics PLC
14/08/202406:00GlobeNewswire Inc.Iterum Therapeutics Reports Second Quarter 2024 Financial ResultsNASDAQ:ITRMIterum Therapeutics PLC
14/08/202406:00GlobeNewswire Inc.Evaxion Announces Business Update and Second Quarter 2024 Financial ResultsNASDAQ:EVAXEvaxion Biotech AS
14/08/202406:00Business WirePowerSchool Expands AI in the Classroom Across Latin AmericaNYSE:PWSCPowerSchool Holdings Inc
14/08/202406:00GlobeNewswire Inc.Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric DisordersNASDAQ:NMRANeumora Therapeutics Inc
14/08/202406:00GlobeNewswire Inc.Shock Top and Gator Athletics Partner to Introduce First-Ever Craft Beer Sponsorship of the Florida Athletic DepartmentNASDAQ:TLRYTilray Brands Inc
14/08/202406:00Business WireValidity Announces Strategic Reseller Partnership with Database Consultants Australia (DCA) to Offer DemandTools Solution
14/08/202406:00GlobeNewswire Inc.CCC, Spain sign contract for DHC-515 FIREFIGHTER™ aircraft
14/08/202406:00GlobeNewswire Inc.Cyber Acoustics Announces AC-6014 USB-C Headset for Classrooms for
14/08/202406:00GlobeNewswire Inc.Global-e Reports Second Quarter 2024 ResultsNASDAQ:GLBEGlobal E Online Ltd
14/08/202406:00GlobeNewswire Inc.Edible Garden Reports 157% Increase in Gross Profit Fueled by Year-over-Year Growth of 61% in Cut Herbs and 30% in Vitamins & Supplements for the Second Quarter of 2024NASDAQ:EDBLWEdible Garden AG Inc
14/08/202406:00GlobeNewswire Inc.Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development PlanNASDAQ:VIRXViracta Therapeutics Inc